These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 34252336)

  • 1. COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines?
    Cooper S; van Rooyen H; Wiysonge CS
    Expert Rev Vaccines; 2021 Aug; 20(8):921-933. PubMed ID: 34252336
    [No Abstract]   [Full Text] [Related]  

  • 2. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context.
    Afolabi AA; Ilesanmi OS
    Pan Afr Med J; 2021; 38():3. PubMed ID: 33520072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance.
    Bellanti JA
    Allergy Asthma Proc; 2021 Sep; 42(5):386-394. PubMed ID: 34372964
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 and the rise of anti-science.
    Hotez P
    Expert Rev Vaccines; 2021 Mar; 20(3):227-229. PubMed ID: 33599568
    [No Abstract]   [Full Text] [Related]  

  • 5. Addressing COVID-19 vaccine hesitancy in South Africa- moving beyond a reliance on information-based responses.
    Cooper S; van Rooyen H; Wiysonge CS
    Hum Vaccin Immunother; 2022 Nov; 18(6):2107851. PubMed ID: 35993844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of COVID-19 vaccine acceptance and hesitancy among adolescents and youths aged 10-35 years in sub-Saharan African countries: A systematic review and meta-analysis.
    Mwiinde AM; Kaonga P; Jacobs C; Zulu JM; Fwemba I
    PLoS One; 2024; 19(10):e0310827. PubMed ID: 39374213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic determinants and reasons for non-acceptance to vaccination recommendations during the 3
    Ligeti AS; Oroszi B; Luca C; Bilics E; Ágoston J; Röst G; Koltai J
    BMC Public Health; 2024 Jul; 24(1):1796. PubMed ID: 38969991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considering Emotion in COVID-19 Vaccine Communication: Addressing Vaccine Hesitancy and Fostering Vaccine Confidence.
    Chou WS; Budenz A
    Health Commun; 2020 Dec; 35(14):1718-1722. PubMed ID: 33124475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccine Hesitancy in South Africa: Lessons for Future Pandemics.
    Engelbrecht M; Heunis C; Kigozi G
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How can a global pandemic affect vaccine hesitancy?
    Dubé E; MacDonald NE
    Expert Rev Vaccines; 2020 Oct; 19(10):899-901. PubMed ID: 32945213
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploring the behavioral determinants of COVID-19 vaccine acceptance among an urban population in Bangladesh: Implications for behavior change interventions.
    Kalam MA; Davis TP; Shano S; Uddin MN; Islam MA; Kanwagi R; Islam A; Hassan MM; Larson HJ
    PLoS One; 2021; 16(8):e0256496. PubMed ID: 34424913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing the elephant in the room: COVID-19 vaccine hesitancy in Black and Asian communities.
    Darko J
    Br J Gen Pract; 2021 Apr; 71(705):170. PubMed ID: 33771793
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling.
    Muhajarine N; Adeyinka DA; McCutcheon J; Green KL; Fahlman M; Kallio N
    PLoS One; 2021; 16(11):e0259513. PubMed ID: 34767603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of COVID-19 vaccine hesitancy among Egyptian healthcare workers: a cross-sectional study.
    El-Sokkary RH; El Seifi OS; Hassan HM; Mortada EM; Hashem MK; Gadelrab MRMA; Tash RME
    BMC Infect Dis; 2021 Aug; 21(1):762. PubMed ID: 34353279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review.
    Deml MJ; Githaiga JN
    BMJ Open; 2022 Nov; 12(11):e066615. PubMed ID: 36400736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Messages that increase COVID-19 vaccine acceptance: Evidence from online experiments in six Latin American countries.
    Argote Tironi P; Barham E; Zuckerman Daly S; Gerez JE; Marshall J; Pocasangre O
    PLoS One; 2021; 16(10):e0259059. PubMed ID: 34710168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking COVID-19 vaccine hesitancy and logistical challenges: A machine learning approach.
    Dutta S; Kumar A; Dutta M; Walsh C
    PLoS One; 2021; 16(6):e0252332. PubMed ID: 34077467
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population.
    Edwards B; Biddle N; Gray M; Sollis K
    PLoS One; 2021; 16(3):e0248892. PubMed ID: 33760836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COVID-19 pandemic momentum: can it be used to support improvements in healthcare worker influenza vaccination?
    Seale H
    Expert Rev Vaccines; 2021 Aug; 20(8):919-920. PubMed ID: 33985390
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethnic and minority group differences in engagement with COVID-19 vaccination programmes - at Pandemic Pace; when vaccine confidence in mass rollout meets local vaccine hesitancy.
    Reid JA; Mabhala MA
    Isr J Health Policy Res; 2021 May; 10(1):33. PubMed ID: 34044891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.